Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

BRAD H ROVIN

Allopathic & Osteopathic Physicians Internal Medicine Nephrology

NPI
1902813215
CMS profile
131002
Location
COLUMBUS, OH

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$116,402.93

83 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

By paying entity

PY2024 · entire year · sorted by reported total

Page 2 of 2; records 51–83 of 83 matching records. This page contains 33 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

BRAD H ROVIN

NPI 1902813215 · CMS profile ID 131002

Allopathic & Osteopathic Physicians / Internal Medicine / Nephrology

COLUMBUS, OH

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 2; records 51–83 of 83 matching records. This page contains 33 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1902813215?year=2024&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
BRAD H ROVIN, NPI 1902813215, CMS profile ID 131002. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–83 of 83 matching records. This page contains 33 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1902813215?year=2024&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
APA 7
IndustryPayments. (2026). BRAD H ROVIN, NPI 1902813215, CMS profile ID 131002. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–83 of 83 matching records. This page contains 33 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1902813215?year=2024&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
Bluebook
BRAD H ROVIN, NPI 1902813215, CMS profile ID 131002, IndustryPayments, General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 2; records 51–83 of 83 matching records. This page contains 33 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff. https://industrypayments.org/provider/npi-1902813215?year=2024&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

83 matching records · $116,402.93 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 83 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–83 of 83.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
E.R. Squibb & Sons, L.L.C. $319.8006/07/2024 Compensation for serving as faculty or as a speaker for a medical education program No dispute reported Delay: No
Change: NEW
06/30/2026 1155175183 CMS
Travere Therapeutics, Inc. $18.4805/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1149937682 CMS
F. Hoffmann-La Roche AG $7,992.5705/24/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1132981997 CMS
F. Hoffmann-La Roche AG $1,623.6905/24/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1132981999 CMS
F. Hoffmann-La Roche AG $67.3305/24/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1132982001 CMS
F. Hoffmann-La Roche AG $925.5005/24/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1132982003 CMS
F. Hoffmann-La Roche AG $6,100.0005/24/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1132982005 CMS
Travere Therapeutics, Inc. $73.4305/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1149937710 CMS
GlaxoSmithKline, LLC. $2,762.5005/15/2024 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1155881707 CMS
Alexion Pharmaceuticals, Inc. $76.9305/03/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1093941254 CMS
Alexion Pharmaceuticals, Inc. $85.7705/02/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1093950007 CMS
Alexion Pharmaceuticals, Inc. $24.9705/02/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1093961798 CMS
Alexion Pharmaceuticals, Inc. $33.4805/01/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1093930418 CMS
Alexion Pharmaceuticals, Inc. $33.5304/30/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1093887459 CMS
Alexion Pharmaceuticals, Inc. $49.9304/30/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1094035107 CMS
Alexion Pharmaceuticals, Inc. $63.3704/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1094009489 CMS
Alexion Pharmaceuticals, Inc. $155.2004/29/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1094044624 CMS
Alexion Pharmaceuticals, Inc. $1,346.5304/28/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1093903874 CMS
Alexion Pharmaceuticals, Inc. $3,098.4004/28/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1094038902 CMS
Novartis Pharmaceuticals Corporation $11.6704/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087315331 CMS
CALLIDITAS THERAPEUTICS US INC. $104.2604/12/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141513241 CMS
Aurinia Pharma U.S., Inc. $22.4103/02/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1150691024 CMS
Regeneron Pharmaceuticals, Inc. $1,260.0002/23/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1114404239 CMS
Novartis Pharmaceuticals Corporation $8,337.5002/09/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087315313 CMS
Novartis Pharmaceuticals Corporation $209.9702/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087315315 CMS
Novartis Pharmaceuticals Corporation $215.7602/09/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087315319 CMS
Novartis Pharmaceuticals Corporation $265.6602/09/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087315321 CMS
Novartis Pharmaceuticals Corporation $46.0002/09/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087315323 CMS
Novartis Pharmaceuticals Corporation $31.9602/09/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087315325 CMS
Novartis Pharmaceuticals Corporation $569.7602/08/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087315311 CMS
Novartis Pharmaceuticals Corporation $21.4202/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087315317 CMS
E.R. Squibb & Sons, L.L.C. $1,525.2301/10/2024 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1155175181 CMS
Travere Therapeutics, Inc. $2.6601/10/2024 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1149937678 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $18,999.76 23
PY2020 $29,808.90 32
PY2021 $34,707.44 18
PY2022 $36,003.23 35
PY2023 $44,486.52 44
PY2024 $116,402.93 83
PY2025 $98,170.24 67

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Recipient $13,598.93 16
PY2024 Recipient $3,476.12 3
PY2023 Recipient $4,046.64 2
PY2022 Principal investigator $302.96 4
PY2021 Principal investigator $63,530.08 7
PY2020 Recipient $249.17 1
PY2020 Principal investigator $34,350.27 25
PY2019 Principal investigator $147,881.65 35

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

16 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Recipient Novartis Pharma AG $975.00 12/17/2025 Covered Recipient Physician CLNP023A2301 No dispute reported 06/30/2026 1248109121
Recipient Novartis Pharma AG $665.08 11/07/2025 Covered Recipient Physician CLNP023A2301 No dispute reported 06/30/2026 1248109119
Recipient Novartis Pharma AG $1,668.08 10/14/2025 Covered Recipient Physician CLNP023A2301 No dispute reported 06/30/2026 1248109117
Recipient Novartis Pharma AG $1,668.10 07/22/2025 Covered Recipient Physician CLNP023A2301 No dispute reported 06/30/2026 1248109115
Recipient Novartis Pharma AG $576.40 06/11/2025 Covered Recipient Physician CLNP023A2301 No dispute reported 06/30/2026 1248109113
Recipient F. Hoffmann-La Roche AG $351.13 05/21/2025 Covered Recipient Physician Randomised Double blind study to evaluate safety and efficacy of Obinutuzumab in Class III and IV LN No dispute reported 06/30/2026 1211534888
Recipient Novartis Pharmaceuticals Corporation $511.90 05/21/2025 Covered Recipient Physician CLNP023A2301 No dispute reported 06/30/2026 1190292483
Recipient F. Hoffmann-La Roche AG $754.82 03/31/2025 Covered Recipient Physician Randomised Double blind study to evaluate safety and efficacy of Obinutuzumab in Class III and IV LN No dispute reported 06/30/2026 1211534892
Recipient F. Hoffmann-La Roche AG $648.69 03/31/2025 Covered Recipient Physician Randomised Double blind study to evaluate safety and efficacy of Obinutuzumab in Class III and IV LN No dispute reported 06/30/2026 1211534896
Recipient F. Hoffmann-La Roche AG $850.40 03/31/2025 Covered Recipient Physician Randomised Double blind study to evaluate safety and efficacy of Obinutuzumab in Class III and IV LN No dispute reported 06/30/2026 1211534899
Recipient F. Hoffmann-La Roche AG $234.86 03/31/2025 Covered Recipient Physician Randomised Double blind study to evaluate safety and efficacy of Obinutuzumab in Class III and IV LN No dispute reported 06/30/2026 1211534903
Recipient F. Hoffmann-La Roche AG $766.64 03/31/2025 Covered Recipient Physician PHII study to examine the effects of Obinutuzumab in patients with Lupus Nephritis No dispute reported 06/30/2026 1211534909
Recipient F. Hoffmann-La Roche AG $351.13 03/31/2025 Covered Recipient Physician Randomised Double blind study to evaluate safety and efficacy of Obinutuzumab in Class III and IV LN No dispute reported 06/30/2026 1211534913
Recipient F. Hoffmann-La Roche AG $2,271.59 03/31/2025 Covered Recipient Physician Randomised Double blind study to evaluate safety and efficacy of Obinutuzumab in Class III and IV LN No dispute reported 06/30/2026 1211534917
Recipient F. Hoffmann-La Roche AG $702.75 03/31/2025 Covered Recipient Physician Randomised Double blind study to evaluate safety and efficacy of Obinutuzumab in Class III and IV LN No dispute reported 06/30/2026 1211534922
Recipient F. Hoffmann-La Roche AG $602.36 03/31/2025 Covered Recipient Physician Randomised Double blind study to evaluate safety and efficacy of Obinutuzumab in Class III and IV LN No dispute reported 06/30/2026 1211534926